Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Orthocell Ltd ( (AU:OCC) ) has issued an update.
Orthocell Limited has released its Corporate Governance Statement, outlining its adherence to the ASX Corporate Governance Council’s Principles and Recommendations. The statement highlights the company’s commitment to maintaining robust governance practices, including clear delineation of roles between the board and management, thorough checks before appointing directors, and accountability of the company secretary to the board. This release underscores Orthocell’s dedication to transparency and accountability, potentially strengthening its position in the biotechnology sector and enhancing stakeholder confidence.
The most recent analyst rating on (AU:OCC) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Orthocell Ltd stock, see the AU:OCC Stock Forecast page.
More about Orthocell Ltd
Orthocell Limited operates in the biotechnology industry, focusing on the development and commercialization of regenerative medicine products. The company is primarily involved in creating innovative treatments for soft tissue injuries and musculoskeletal disorders, aiming to improve patient outcomes and quality of life.
Average Trading Volume: 617,569
Technical Sentiment Signal: Buy
Current Market Cap: A$293.8M
See more insights into OCC stock on TipRanks’ Stock Analysis page.